InChI
1S/Bi
SMILES string
[Bi]
InChI key
JCXGWMGPZLAOME-UHFFFAOYSA-N
vapor pressure
<0.1 mmHg ( 20 °C)
assay
99.97%
form
foil
manufacturer/tradename
Goodfellow 502-432-84
resistivity
129 μΩ-cm, 20°C
size × thickness
150 x 150 mm × 0.05 mm
bp
1560 °C (lit.)
mp
271 °C (lit.)
density
9.8 g/mL at 25 °C (lit.)
正在寻找类似产品? 访问 产品对比指南
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
法规信息
新产品
此项目有
Ruiguang Ge et al.
Metallomics : integrated biometal science, 4(3), 239-243 (2012-02-24)
Helicobacter pylori causes various gastric diseases, such as gastritis, peptic ulcerations and gastric cancer. Bismuth-based triple or quadruple therapies have been commonly recommended for the treatment of H. pylori infections. Up to now, the molecular mechanisms by which bismuth inhibits
Hong Lu et al.
European journal of gastroenterology & hepatology, 25(10), 1134-1140 (2013-06-20)
Antimicrobial resistance has continued to undermine many popular anti-Helicobacter pylori therapies. Antibiotic resistance to commonly used anti-H. pylori drugs in China has increased markedly, making China an ideal site to identify regimens that remain effective despite widespread antimicrobial resistance. Bismuth
Jorge A R Salvador et al.
Molecules (Basel, Switzerland), 16(4), 2884-2913 (2011-04-06)
Steroid and terpene chemistry still have a great impact on medicinal chemistry. Therefore, the development of new reactions or "greener" processes in this field is a contemporaneous issue. In this review, the use of bismuth(III) salts, as "ecofriendly" reagents/catalysts, on
P Moayyedi et al.
Alimentary pharmacology & therapeutics, 17(10), 1215-1227 (2003-05-21)
Evidence for the effectiveness of antacids, histamine-2 receptor antagonists, bismuth salts, sucralfate and prokinetic therapy in non-ulcer dyspepsia is conflicting. To conduct a systematic review evaluating these therapies in non-ulcer dyspepsia. Electronic searches were performed using the Cochrane Controlled Trials
Andreia M C Rocha et al.
British journal of haematology, 168(3), 421-428 (2014-09-27)
Helicobacter pylori eradication induces platelet recovery in a subgroup of patients with chronic immune thrombocytopenia (cITP), but the mechanisms involved are still not understood. We aimed to evaluate the effect of H. pylori eradication on platelet response and to identify the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持